T-cell Large Granular Lymphocytic Leukemia
specificA T-cell peripheral neoplasm characterized by a persistent (>6 months) increase in the number of peripheral blood large granular lymphocytes, without a clearly identified cause. (WHO, 2001)
13
Centers
15
Active Trials
—
Cancer Funding
Top Centers for T-cell Large Granular Lymphocytic Leukemia(13)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive High-Volume Research Center | 72.9 |
| 2 | Boston University Cancer CenterBoston, MA High-Volume Research Center | 72.9 |
| 3 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 50.4 |
| 4 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 50.4 |
| 5 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 50.4 |
| 6 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 50.4 |
| 7 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 50.4 |
| 8 | NCI Clinical Active Research Program | 50.4 |
| 9 | Cleveland Clinic Cancer CenterCleveland, OH Active Research Program | 50.4 |
| 10 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 50.4 |
| 11 | University of Illinois Cancer CenterChicago, IL Active Research Program | 50.4 |
| 12 | Cancer Center at IllinoisUrbana, IL Active Research Program | 50.4 |
| 13 | Active Research Program | 50.4 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →